These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


354 related items for PubMed ID: 18410774

  • 1. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents.
    Bahar RJ, Collins BS, Steinmetz B, Ament ME.
    J Pediatr; 2008 May; 152(5):685-9. PubMed ID: 18410774
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
    Chang FY, Lu CL, Chen CY, Luo JC.
    J Gastroenterol Hepatol; 2007 Dec 15; 22(12):2266-72. PubMed ID: 17559369
    [Abstract] [Full Text] [Related]

  • 4. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
    Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG.
    Am J Gastroenterol; 2008 Oct 15; 103(10):2562-9. PubMed ID: 18775020
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 15; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 8. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome.
    Vahedi H, Merat S, Momtahen S, Kazzazi AS, Ghaffari N, Olfati G, Malekzadeh R.
    Aliment Pharmacol Ther; 2008 Apr 15; 27(8):678-84. PubMed ID: 18248658
    [Abstract] [Full Text] [Related]

  • 9. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial.
    Pace F, Maurano A, Ciacci C, Savarino V, Attili A, Iaquinto G, Magni E, Porro GB.
    Eur Rev Med Pharmacol Sci; 2010 Mar 15; 14(3):155-62. PubMed ID: 20391952
    [Abstract] [Full Text] [Related]

  • 10. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK, Wu JC, Liang SM, Chan LS, Chan FK, Xie H, Fung SS, Hui AJ, Wong VW, Che CT, Sung JJ.
    Am J Gastroenterol; 2006 Jul 15; 101(7):1574-80. PubMed ID: 16863563
    [Abstract] [Full Text] [Related]

  • 11. Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study.
    Sohn W, Lee OY, Kwon JG, Park KS, Lim YJ, Kim TH, Jung SW, Kim JI.
    Neurogastroenterol Motil; 2012 Sep 15; 24(9):860-e398. PubMed ID: 22679908
    [Abstract] [Full Text] [Related]

  • 12. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
    Tuteja AK, Fang JC, Al-Suqi M, Stoddard GJ, Hale DC.
    Scand J Gastroenterol; 2012 Oct 15; 47(10):1159-64. PubMed ID: 22783919
    [Abstract] [Full Text] [Related]

  • 13. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
    Mangel AW, Bornstein JD, Hamm LR, Buda J, Wang J, Irish W, Urso D.
    Aliment Pharmacol Ther; 2008 Jul 15; 28(2):239-49. PubMed ID: 18466359
    [Abstract] [Full Text] [Related]

  • 14. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
    Cain KC, Headstrom P, Jarrett ME, Motzer SA, Park H, Burr RL, Surawicz CM, Heitkemper MM.
    Am J Gastroenterol; 2006 Jan 15; 101(1):124-32. PubMed ID: 16405544
    [Abstract] [Full Text] [Related]

  • 15. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
    Chey WD, Paré P, Viegas A, Ligozio G, Shetzline MA.
    Am J Gastroenterol; 2008 May 15; 103(5):1217-25. PubMed ID: 18477346
    [Abstract] [Full Text] [Related]

  • 16. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
    Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M.
    J Pediatr Gastroenterol Nutr; 2010 Jul 15; 51(1):24-30. PubMed ID: 20453678
    [Abstract] [Full Text] [Related]

  • 17. The effect of trimebutine on the psychosocial adjustment to illness in the irritable bowel syndrome.
    Dumitraşcu DL, Stănculete M.
    Rom J Intern Med; 2006 Jul 15; 44(3):273-80. PubMed ID: 18386606
    [Abstract] [Full Text] [Related]

  • 18. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome.
    Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J, OBIS Study Investigators.
    Aliment Pharmacol Ther; 2011 Aug 15; 34(4):432-42. PubMed ID: 21679214
    [Abstract] [Full Text] [Related]

  • 19. A preliminary study of melatonin in irritable bowel syndrome.
    Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P.
    J Clin Gastroenterol; 2007 Jan 15; 41(1):29-32. PubMed ID: 17198061
    [Abstract] [Full Text] [Related]

  • 20. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC, Croffut RM, Stranahan MC.
    Clin Ther; 2005 Jun 15; 27(6):755-61. PubMed ID: 16117982
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.